Vaccine
![Sanofi Invests $175M in J&J's Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts](https://pharmtales.com/wp-content/uploads/2023/10/Sanofi-Invests-175M-in-JJs-Advanced-E.-coli-Vaccine-Amplifying-its-Vaccine-Development-Efforts.jpg)
Sanofi Invests $175M in J&J’s Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts
Sanofi is making a strategic move by investing $175 million in Johnson & Johnson’s late-phase E. coli vaccine, ExPEC9V. As ...
![arcturus therapeutics, sa-mrna, covid-19, vaccine, booster, immune response, phase 1/2 trial](https://pharmtales.com/wp-content/uploads/2023/09/Arcturus-reports-positive-results-for-sa-mRNA-COVID-boosters-in-phase-1_2-trial.jpg)
Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial
Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...
![Sanofi, Ice-T, flu shot, vaccine,Video campaign, Flu season](https://pharmtales.com/wp-content/uploads/2023/09/Sanofi-teams-up-with-Ice-T-to-scare-people-into-getting-flu-shots.jpg)
Sanofi teams up with Ice-T to scare people into getting flu shots
Sanofi is breaking the mold with a bold and captivating campaign aimed at alerting older adults to the perils of ...
![Moderna, COVID-19 booster, vaccine, low demand, manufacturing](https://pharmtales.com/wp-content/uploads/2023/09/Moderna-to-cut-down-COVID-booster-production-amid-low-demand-Reuters-reports.jpg)
Moderna to cut down COVID booster production amid low demand: Reuters reports
While the FDA and the Centers for Disease Control and Prevention (CDC) have given their green light to updated COVID ...
![Novavax, SK Bioscience, Covid 19, Vaccine](https://pharmtales.com/wp-content/uploads/2023/08/SK-Bioscience-invests-85M-on-a-7-share-in-the-vaccine-manufacturer-Novavax-to-keep-it-afloat.jpg)
SK Bioscience invests $85M on a 7% share in the vaccine manufacturer, Novavax, to keep it afloat
Following its setback during the pandemic phase of COVID-19 with a delayed vaccine, Novavax is now aiming for recovery in ...
![Pfizer Unveils Promising GBS Maternal Vaccine in New England Journal of Medicine](https://pharmtales.com/wp-content/uploads/2023/07/Pfizer-Unveils-Promising-GBS-Maternal-Vaccine-in-New-England-Journal-of-Medicine.jpg)
Pfizer Unveils Promising GBS Maternal Vaccine in New England Journal of Medicine
Source – Pfizer On July 19, Pfizer released promising data from a Phase II study of their GBS6 vaccine candidate, ...
![The FDA expedites the development of GSK's vaccine for gonorrhea _ Pharmtales - Latest Pharma News & Insights](https://pharmtales.com/wp-content/uploads/2023/06/The-FDA-expedites-the-development-of-GSKs-vaccine-for-gonorrhea-_-Pharmtales-Latest-Pharma-News-Insights.jpg)
The FDA expedites the development of GSK’s vaccine for gonorrhea
Source – GSK GSK’s vaccine for gonorrhea has received a fast-track designation from the FDA, signaling its potential to combat ...